论文部分内容阅读
我们自1988年以来,应用食道心房调搏术(TEAP)对34例阵发性室上性心动过速(PSVT)患儿作出分型诊断;同时应用程序电刺激评价和指导临床用药,取得了较满意的疗效.全组病例均为一次静脉给药(异搏定、胺碘酮、异丙吡胺)后复律.无1例应用电转复治疗者.1年后复发律为5.88%.同时,选择了31例PSVT 患儿,应用异搏定、胺碘酮、异丙吡胺等药物作常规转复,结果显示:用药疗程较长,疗效不稳定;仅电击复律数即迭9人.1年后复发率为38.71%.两组对照,经统计学处理,P<0.005,有极显著差异.
We have used 34 cases of paroxysmal supraventricular tachycardia (PSVT) to diagnose subtypes of children with esophageal atrial pacing (TEAP) since 1988 and evaluated the application of electrical stimulation to guide the clinical use of the drug More satisfactory curative effect.All patients were intravenous administration (verapamil, amiodarone, clove-dipyridamole) cardioversion.None of the cases applied electroregulation therapy.The relapse law was 5.88% after 1 year. At the same time, 31 cases of PSVT children were selected, verapamil, amiodarone, cloesperide and other drugs for routine conversion, the results showed that: longer course of treatment, curative effect is unstable; One year after the recurrence rate was 38.71% .Two groups of control, the statistical analysis, P <0.005, a very significant difference.